Profile | GDS5420 / 217388_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 3069.42 | 94 |
GSM1296119 | B_lesional_pre-dose | 3520.45 | 95 |
GSM1296076 | C_lesional_pre-dose | 2752.76 | 92 |
GSM1296092 | D_lesional_pre-dose | 4118.68 | 96 |
GSM1296103 | E_lesional_pre-dose | 5616.44 | 98 |
GSM1296078 | F_lesional_pre-dose | 2873.25 | 92 |
GSM1296107 | G_lesional_pre-dose | 2285.93 | 91 |
GSM1296109 | H_lesional_pre-dose | 3002.7 | 94 |
GSM1296080 | I_lesional_pre-dose | 3730.02 | 95 |
GSM1296090 | J_lesional_pre-dose | 3244.6 | 94 |
GSM1296074 | K_lesional_pre-dose | 4090.18 | 95 |
GSM1296111 | L_lesional_pre-dose | 2559.69 | 92 |
GSM1296099 | M_lesional_pre-dose | 3343.4 | 95 |
GSM1296086 | O_lesional_pre-dose | 2945.34 | 93 |
GSM1296117 | P_lesional_pre-dose | 3555.19 | 96 |
GSM1296113 | Q_lesional_pre-dose | 1617.69 | 87 |
GSM1296096 | R_lesional_pre-dose | 3073.65 | 94 |
GSM1296105 | S_lesional_pre-dose | 1589.19 | 86 |
GSM1296098 | T_lesional_pre-dose | 3222.3 | 94 |
GSM1296101 | U_lesional_pre-dose | 2210.9 | 90 |
GSM1296121 | V_lesional_pre-dose | 3213.89 | 94 |
GSM1296088 | W_lesional_pre-dose | 3045.91 | 94 |
GSM1296082 | X_lesional_pre-dose | 3553.95 | 94 |
GSM1296115 | Y_lesional_pre-dose | 2830.81 | 93 |
GSM1296084 | Z_lesional_pre-dose | 1634.79 | 86 |
GSM1296072 | B_lesional_day8 | 1687.06 | 87 |
GSM1296069 | L_lesional_day8 | 985.09 | 79 |
GSM1296071 | P_lesional_day8 | 631.23 | 71 |
GSM1296070 | Y_lesional_day8 | 1198.89 | 82 |
GSM1296073 | V_lesional_day8 | 3501.03 | 95 |
GSM1296034 | A_lesional_day15 | 401.64 | 63 |
GSM1296041 | G_lesional_day15 | 2925.33 | 93 |
GSM1296035 | R_lesional_day15 | 2556.28 | 92 |
GSM1296038 | U_lesional_day15 | 1230.62 | 82 |
GSM1296047 | B_lesional_day15 | 1286.79 | 83 |
GSM1296039 | E_lesional_day15 | 4064.38 | 95 |
GSM1296042 | H_lesional_day15 | 2462.53 | 92 |
GSM1296043 | L_lesional_day15 | 1037.54 | 80 |
GSM1296037 | M_lesional_day15 | 334.69 | 60 |
GSM1296046 | P_lesional_day15 | 295.76 | 58 |
GSM1296044 | Q_lesional_day15 | 417.69 | 64 |
GSM1296045 | Y_lesional_day15 | 929.41 | 78 |
GSM1296025 | C_lesional_day15 | 328.19 | 61 |
GSM1296033 | D_lesional_day15 | 1517.83 | 85 |
GSM1296027 | I_lesional_day15 | 736.91 | 74 |
GSM1296032 | J_lesional_day15 | 436.81 | 65 |
GSM1296024 | K_lesional_day15 | 505.9 | 68 |
GSM1296031 | W_lesional_day15 | 316.46 | 59 |
GSM1296028 | X_lesional_day15 | 928.18 | 78 |
GSM1296029 | Z_lesional_day15 | 559.9 | 69 |
GSM1296026 | F_lesional_day15 | 2294.02 | 90 |
GSM1296030 | O_lesional_day15 | 2879.99 | 93 |
GSM1296040 | S_lesional_day15 | 1533.01 | 86 |
GSM1296036 | T_lesional_day15 | 3167.82 | 95 |
GSM1296048 | V_lesional_day15 | 3006.34 | 94 |
GSM1296059 | A_lesional_day43 | 3112.62 | 94 |
GSM1296066 | G_lesional_day43 | 1990.86 | 89 |
GSM1296060 | R_lesional_day43 | 2971.45 | 94 |
GSM1296063 | U_lesional_day43 | 2309.78 | 91 |
GSM1296064 | E_lesional_day43 | 4795.79 | 96 |
GSM1296067 | H_lesional_day43 | 1008.31 | 80 |
GSM1296062 | M_lesional_day43 | 3118.52 | 95 |
GSM1296068 | Q_lesional_day43 | 412.15 | 63 |
GSM1296050 | C_lesional_day43 | 277.34 | 58 |
GSM1296057 | D_lesional_day43 | 1251.32 | 82 |
GSM1296052 | I_lesional_day43 | 597.56 | 71 |
GSM1296054 | J_lesional_day43 | 448.12 | 65 |
GSM1296049 | K_lesional_day43 | 426.69 | 65 |
GSM1296055 | W_lesional_day43 | 409.3 | 64 |
GSM1296053 | X_lesional_day43 | 626.18 | 71 |
GSM1296058 | Z_lesional_day43 | 623.06 | 71 |
GSM1296051 | F_lesional_day43 | 2359.78 | 91 |
GSM1296056 | O_lesional_day43 | 3119.04 | 93 |
GSM1296065 | S_lesional_day43 | 1475.02 | 85 |
GSM1296061 | T_lesional_day43 | 1917.47 | 89 |
GSM1296095 | A_non-lesional_pre-dose | 290.97 | 59 |
GSM1296120 | B_non-lesional_pre-dose | 340.75 | 61 |
GSM1296077 | C_non-lesional_pre-dose | 285.7 | 59 |
GSM1296093 | D_non-lesional_pre-dose | 344.72 | 61 |
GSM1296104 | E_non-lesional_pre-dose | 456.19 | 66 |
GSM1296079 | F_non-lesional_pre-dose | 565.65 | 70 |
GSM1296108 | G_non-lesional_pre-dose | 169.61 | 49 |
GSM1296110 | H_non-lesional_pre-dose | 300.42 | 58 |
GSM1296081 | I_non-lesional_pre-dose | 212.55 | 54 |
GSM1296091 | J_non-lesional_pre-dose | 226.96 | 55 |
GSM1296075 | K_non-lesional_pre-dose | 238.86 | 57 |
GSM1296112 | L_non-lesional_pre-dose | 193.44 | 49 |
GSM1296100 | M_non-lesional_pre-dose | 186.56 | 50 |
GSM1296087 | O_non-lesional_pre-dose | 575.53 | 70 |
GSM1296118 | P_non-lesional_pre-dose | 251.31 | 55 |
GSM1296114 | Q_non-lesional_pre-dose | 218.88 | 52 |
GSM1296097 | R_non-lesional_pre-dose | 308.7 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 266.78 | 56 |
GSM1296102 | U_non-lesional_pre-dose | 207.94 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 321.27 | 60 |
GSM1296089 | W_non-lesional_pre-dose | 163.06 | 48 |
GSM1296083 | X_non-lesional_pre-dose | 314.68 | 60 |
GSM1296116 | Y_non-lesional_pre-dose | 249.55 | 54 |
GSM1296085 | Z_non-lesional_pre-dose | 122.23 | 45 |